Clinical Trials in Pennsylvania

Showing 6601-6620 of 14,950 trials

A Prospective Clinical Study of Phenylketonuria (PKU)

NCT04452513

This is a study for adults and children ≥ 14 years old who have Phenylketonuria (PKU) with uncontrolled plasma Phe levels. No clinical intervention or study drug is provided by BioMarin in this study.

Phenylketonurias

BioMarin Pharmaceutical32 participantsStarted Oct 2019

Aurora, Colorado, United States • Gainesville, Florida, United States • Tampa, Florida, United States +11 more locations

COMPLETEDPhase 388 miles

Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia

NCT03503318

The purpose of the study is to evaluate the efficacy, safety, and tolerability of different dose regimens of TV-46000 administered subcutaneously (SC) as compared to placebo during maintenance treatment in adult and adolescent participants with schizophrenia. The study will include male and female participants, 13 to 65 years of age, who have a confirmed diagnosis of schizophrenia, are clinically stable, and are eligible for risperidone treatment

Schizophrenia

Teva Branded Pharmaceutical Products R&D, Inc.544 participantsStarted Apr 2018

Little Rock, Arkansas, United States • Rogers, Arkansas, United States • Anaheim, California, United States +78 more locations

A Prospective Clinical Study of Phenylketonuria (PKU)

Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia

Find Trials by Condition in Pennsylvania

A 24-Week Treatment Study to Compare Standard of Care Versus the eMDPI DS in Participants 13 Years or Older With Asthma

A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]

A Study to Test if TEV-48574 is Effective in Relieving Asthma

Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension

Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus

A Randomized, Controlled Trial of Ganaxolone in Adult Uncontrolled Partial-Onset Seizures

Evaluation of Performance of the LumiraDx Influenza A/B + RSV Test at POC Testing Sites

An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy

Reducing the Effects of Active Surveillance Stress, Uncertainty and Rumination Thru Engagement in Mindfulness Education

Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma

Transmural Systems Transcaval Closure Device for Transcaval Access Ports During Transcatheter Aortic Valve Replacement

A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer

Assessment of Safety and Efficacy of Nerivio for the Migraine Prevention

AMBULATE Continued Access Protocol to Evaluate the Cardiva Mid-Bore Venous Vascular Closure System (VVCS)

The Effects of Evolocumab in Patients With Diabetes and Atherosclerotic Vascular Disease

A Phase II Study in Patients With Moderate to Severe Active Crohn's Disease

A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease

A PK, Safety and Tolerability Study of Peripheral and Central Infusion of Melflufen in RRMM Patients